Results 151 to 160 of about 119,278 (243)

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

First Study on Antimicrobial Susceptibility and Molecular Epidemiology of <i>Neisseria gonorrhoeae</i> Isolates from Infertile Women. [PDF]

Infect Drug Resist
Huang Y, Hu J, Ji H, He X, Liu J, Wu T, Wang J, Liu G.   +7 more
europepmc   +1 more source

Serologic response to VDRL in infants with congenital syphilis: ceftriaxone vs. penicillin. [PDF]

J Pediatr (Rio J)
Cavalcante ANM, Araújo MAL, Soares BSC, Nobre MA, de Almeida RLF.   +4 more
europepmc   +1 more source

Evaluating Outpatient Parenteral Antimicrobial Therapy (OPAT) Clinic for Pediatric Infectious Conditions: Insights From Alberta Children's Hospital. [PDF]

Can J Infect Dis Med Microbiol
Alsharrah D, Jadavji T.
europepmc   +1 more source

A Case of Neuro- and Otosyphilis Successfully Managed with a Sequential Regimen Including Ceftriaxone. [PDF]

Infect Drug Resist
Zhou QY, Wang SN, Xu LX, Zhang YB, Zhang RL, Wang QQ.   +5 more
europepmc   +1 more source

Comparison of Patient Outcomes in a Pharmacist-Led Parenteral Antimicrobial Therapy Program [PDF]

, 2020
Howe, Zachary W., McCann, Jennifer, Saum, Lindsay   +2 more
core   +1 more source

Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin. [PDF]

Int J Urol
Balık AY, Ediz E, Ayvacık B, Taşkıran AT, Başaran E, Baba D.   +5 more
europepmc   +1 more source

Ceftriaxone-Induced Immune Hemolytic Anemia and Subsequent Disseminated Intravascular Coagulation. [PDF]

Cureus
Pham HT, Bach J, Kolacki C, Jones JS, DeBruine N.   +4 more
europepmc   +1 more source

Antibiotic-resistance mutations in penicillin-binding protein 2 from the ceftriaxone-resistant Neisseria gonorrhoeae strain H041 strike a delicate balance between increasing resistance and maintaining transpeptidase activity. [PDF]

PLoS Pathog
Bivins MM, Tomberg J, Bagshaw M, Singh A, Bala S, Davies C, Nicholas RA.   +6 more
europepmc   +1 more source

Ceftriaxone-induced Kounis syndrome presenting with arrhythmia: a case report and literature review from a resource-limited setting. [PDF]

Ann Med Surg (Lond)
Ayen AA, Nur WA, Bezie GA, Ibrahim MA, Hassan MA, Mohamud AA, Agmas AD, Gamadid AI, Hussen MM, Birhan YA.   +9 more
europepmc   +1 more source